US would block certain investments in Chinese biotechnology to protect drug supply.
This bill would add biotechnology to a list of sensitive technologies where US investments in certain foreign companies are restricted. It aims to prevent US money and knowledge from helping countries like China dominate the global drug supply chain. This could help protect America's national security and access to important medicines.
Currently, US investments in foreign biotechnology companies are not specifically covered by national security screening rules under the Defense Production Act. If this bill becomes law, the US government would gain the power to review and potentially block certain US investments in foreign biotechnology. This would particularly apply to those involving countries like China, aiming to protect national security and the drug supply.
S 5316 · 119th Congress · AI Summary by gemini-2.5-flash · 9/10
Sign in to see your representatives' phone numbers